199 related articles for article (PubMed ID: 19696980)
1. [Gastrointestinal stromal tumors: recommendations for diagnosis, treatment and aftercare in Austria].
Ploner F; Zacherl J; Wrba F; Längle F; Bareck E; Eisterer W; Kühr T; Schima W; Häfner M; Brodowicz T;
Wien Med Wochenschr; 2009; 159(15-16):370-82. PubMed ID: 19696980
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal stromal tumors: diagnosis, therapy and follow-up care in Austria.
Bareck E; Ba-Ssalamah A; Brodowicz T; Eisterer W; Häfner M; Högenauer C; Kastner U; Kühr T; Längle F; Liegl-Atzwanger B; Schoppmann SF; Widmann G; Wrba F; Zacherl J; Ploner F;
Wien Med Wochenschr; 2013 Mar; 163(5-6):137-52. PubMed ID: 23508516
[TBL] [Abstract][Full Text] [Related]
3. [The importance of mutational status in prognosis and therapy of GIST].
Comandone A; Boglione A
Recenti Prog Med; 2015 Jan; 106(1):17-22. PubMed ID: 25621775
[TBL] [Abstract][Full Text] [Related]
4. [GIST: adjuvant treatment in Austria].
Brodowicz T; Kühr T
Wien Med Wochenschr; 2009; 159(15-16):399-402. PubMed ID: 19696984
[TBL] [Abstract][Full Text] [Related]
5. [Gastrointestinal stromal tumour (GIST): current standards in multimodal management].
Reichardt P; Reichardt A
Zentralbl Chir; 2011 Aug; 136(4):359-63. PubMed ID: 21863513
[TBL] [Abstract][Full Text] [Related]
6. Multidisciplinary treatment of gastrointestinal stromal tumors.
Kingham TP; DeMatteo RP
Surg Clin North Am; 2009 Feb; 89(1):217-33, x. PubMed ID: 19186237
[TBL] [Abstract][Full Text] [Related]
7. [Surgical treatment of gastrointestinal stromal tumors].
Bareck E; Längle F; Zacherl J
Wien Med Wochenschr; 2009; 159(15-16):393-8. PubMed ID: 19696983
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors for long-term effects of imatinib therapy in patients with inoperable/metastatic CD117(+) gastrointestinal stromal tumors (GISTs).
Rutkowski P; Nowecki ZI; Debiec-Rychter M; Grzesiakowska U; Michej W; Woźniak A; Siedlecki JA; Limon J; vel Dobosz AJ; Kakol M; Osuch C; Ruka W
J Cancer Res Clin Oncol; 2007 Sep; 133(9):589-97. PubMed ID: 17458563
[TBL] [Abstract][Full Text] [Related]
9. Response to imatinib in KIT- and PDGFRA-wild type gastrointestinal stromal associated with neurofibromatosis type 1.
Lee JL; Kim JY; Ryu MH; Kang HJ; Chang HM; Kim TW; Lee H; Park JH; Kim HC; Kim JS; Kang YK
Dig Dis Sci; 2006 Jun; 51(6):1043-6. PubMed ID: 16865565
[No Abstract] [Full Text] [Related]
10. Perioperative treatment of gastrointestinal stromal tumors.
Fernandes Gdos S; Blanke CD; Freitas D; Guedes R; Hoff PM
Oncology (Williston Park); 2009 Jan; 23(1):54-61. PubMed ID: 19283922
[TBL] [Abstract][Full Text] [Related]
11. [Gastrointestinal stromal tumors (GIST) - clinical experience and current therapeutical aspects].
Iarŭmov N; Velev G; Todorov G; Lukanova Ts; Angelov K; Gribnev P; Sokolov M; Toshev S
Khirurgiia (Sofiia); 2007; (4):27-32. PubMed ID: 18443532
[TBL] [Abstract][Full Text] [Related]
12. [Gastrointestinal stromal tumors: evolution of a tumor concept from unclassifiable neoplasms to targeted molecular therapy].
Agaimy A; Schneider-Stock R
Pathologe; 2010 Mar; 31(2):115-22. PubMed ID: 19949796
[TBL] [Abstract][Full Text] [Related]
13. Correlation of imatinib resistance with the mutational status of KIT and PDGFRA genes in gastrointestinal stromal tumors: a meta-analysis.
Lee JH; Kim Y; Choi JW; Kim YS
J Gastrointestin Liver Dis; 2013 Dec; 22(4):413-8. PubMed ID: 24369323
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal stromal tumors, version 2.2014.
von Mehren M; Randall RL; Benjamin RS; Boles S; Bui MM; Casper ES; Conrad EU; DeLaney TF; Ganjoo KN; George S; Gonzalez RJ; Heslin MJ; Kane JM; Mayerson J; McGarry SV; Meyer C; O'Donnell RJ; Pappo AS; Paz IB; Pfeifer JD; Riedel RF; Schuetze S; Schupak KD; Schwartz HS; Van Tine BA; Wayne JD; Bergman MA; Sundar H
J Natl Compr Canc Netw; 2014 Jun; 12(6):853-62. PubMed ID: 24925196
[TBL] [Abstract][Full Text] [Related]
15. Imatinib and gastrointestinal stromal tumors: Where do we go from here?
De Giorgi U; Verweij J
Mol Cancer Ther; 2005 Mar; 4(3):495-501. PubMed ID: 15767559
[TBL] [Abstract][Full Text] [Related]
16. [Chinese consensus in diagnosis and treatment of gastrointestinal stromal tumor].
Chinese Diagnosis and Treatment Experts Group for Gastrointestinal Stromal Tumors
Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):697-702. PubMed ID: 20078976
[No Abstract] [Full Text] [Related]
17. Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group.
Heinrich MC; Owzar K; Corless CL; Hollis D; Borden EC; Fletcher CD; Ryan CW; von Mehren M; Blanke CD; Rankin C; Benjamin RS; Bramwell VH; Demetri GD; Bertagnolli MM; Fletcher JA
J Clin Oncol; 2008 Nov; 26(33):5360-7. PubMed ID: 18955451
[TBL] [Abstract][Full Text] [Related]
18. Clinical practice guideline for accurate diagnosis and effective treatment of gastrointestinal stromal tumor in Korea.
Kang YK; Kim KM; Sohn T; Choi D; Kang HJ; Ryu MH; Kim WH; Yang HK;
J Korean Med Sci; 2010 Nov; 25(11):1543-52. PubMed ID: 21060741
[TBL] [Abstract][Full Text] [Related]
19. Imatinib treatment for gastrointestinal stromal tumour (GIST).
Lopes LF; Bacchi CE
J Cell Mol Med; 2010 Jan; 14(1-2):42-50. PubMed ID: 19968734
[TBL] [Abstract][Full Text] [Related]
20. [Etiology of and therapy for gastrointestinal stromal tumor].
Shinomura Y
Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1939-45. PubMed ID: 17037339
[No Abstract] [Full Text] [Related]
[Next] [New Search]
